Health Care & Life Sciences » Biotechnology | Sangamo BioSciences Inc.

Sangamo BioSciences Inc.

Sangamo BioSciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
101.67 M
Public Float
87.1 M
Sangamo BioSciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.89
Market Cap
$1.17 B
Shares Outstanding
115.36 M
Public Float
101.84 M

Profile

Address
Point Richmond Tech Center II
Richmond California 94804
United States
Employees -
Website http://www.sangamo.com
Updated 07/08/2019
Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O.

Financials

View All

Alexander Macrae
President, Chief Executive Officer & Director
Karen L. Smith
Director